New Drug Resistance Index Ranks 41 Countries, Shows Distinctions Between High-, Low-Income Nations

CIDRAP News: New metric aims to simplify how global resistance is measured
“A new method for measuring and tracking antibiotic resistance and comparing the effectiveness of antibiotics by country shows a clear distinction between high- and low-income countries. In a study published in BMJ Global Health, researchers from the Center for Disease Dynamics, Economics & Policy (CDDEP) calculated the Drug Resistance Index (DRI) — which combines measurements of antibiotic consumption and resistance across several disease-causing pathogens — for 41 countries. … DRIs were generally correlated with income levels, with high-income countries such as Sweden, Canada, and Norway having the lowest DRIs and India, Thailand, and Ecuador the highest…” (Dall, 4/18).